GlassScriptPhysician profile
Jodi L Fox
NPI 1508848284
$10,541.05
in general payments reported to CMS, 2019-2025
44 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2020: $1,450 · 2021: $2,119 · 2022: $2,132 · 2023: $1,463 · 2024: $1,285 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,790.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,496.17 | 2019-2025 | |
| Lilly USA, LLC | $1,418.74 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,323.32 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $958.63 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $737.21 | 2019-2024 | Otezla, Repatha, Evenity |
| Pfizer INC. | $671.79 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.80 | 2020-2024 | Jardiance, Tradjenta |
| Glaxosmithkline, LLC. | $337.01 | 2021-2025 | Trelegy Ellipta |
| Allergan, INC. | $268.56 | 2020 | |
| Sumitomo Pharma America, INC. | $244.10 | 2023-2025 | Gemtesa |
| Eisai INC. | $235.50 | 2020-2021 | |
| Dexcom, INC. | $222.69 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $200.63 | 2019-2021 | |
| Abbott Laboratories | $186.00 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2, Freestyle Libre |
| Merck Sharp & Dohme LLC | $180.48 | 2020-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.